© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Estrella Immunopharma, Inc. (ESLA) shows an Average True Range (ATR) of 0.28 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 290.73K, indicating liquidity. These fundamental metrics provide insight into ESLA's underlying financial health and market activity.
Estrella Immunopharma, Inc. (ESLA) technical indicators as of December 22, 2025: the SMA 20 is -6.76%, SMA 50 at -16.52%, and SMA 200 at 36.12%. The RSI 14 value is 45.21, suggesting its current momentum. These technical analysis signals help assess ESLA's price trends and potential future movements.
Estrella Immunopharma, Inc. (ESLA) stock performance overview as of December 22, 2025: The 52-week high is $3.15 (currently -46.35% below), and the 52-week low is $0.73 (currently 131.48% above). Over the past year, ESLA's performance is 42.02%, compared to the S&P 500's 12.87% change.
According to market data, Estrella Immunopharma, Inc. (ESLA) stock's recent performance metrics show that over the last month, ESLA is -7.14%, with a Year-to-Date (YTD) performance of 40.83%. Over the past year, the stock has seen a 42.02% change. These figures summarize ESLA's price movements across various periods, reflecting its historical returns.
According to current financial data, ESLA stock's P/E (TTM) ratio is -4.64, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ESLA, including P/S (N/A), P/B (-6.37), and P/FCF (-25.49), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.